Ferrosan

Part of Pfizer

CompanyDenmark

Ferrosan develops one asset, in phase 3, no development reported (glucosamine in back pain). Mostly small molecule; based in Denmark.

1
Asset
Furthest stage
Phase 3, no development reported
1
Trial
3
Signals

Pipeline

1
  • glucosamine

    Supports cartilage matrix synthesis and maintenance.

    Phase 3, no development reported, Small molecule, back pain, knee osteoarthritis

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms1
  • Trials2
  • Signals17
  • Similar companies6

Intelligence